VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,442 | -10.6% | 13,543 | 0.0% | 0.03% | -7.1% |
| Q2 2023 | $407,780 | -6.9% | 13,543 | 0.0% | 0.03% | -12.5% |
| Q1 2023 | $438,116 | +12.2% | 13,543 | -0.6% | 0.03% | -8.6% |
| Q4 2022 | $390,464 | +13.8% | 13,624 | -4.2% | 0.04% | +16.7% |
| Q3 2022 | $343,000 | -11.4% | 14,219 | +0.6% | 0.03% | -6.2% |
| Q2 2022 | $387,000 | -55.9% | 14,130 | -38.2% | 0.03% | -52.2% |
| Q1 2022 | $877,000 | -3.8% | 22,866 | -23.5% | 0.07% | -5.6% |
| Q4 2021 | $912,000 | +3.8% | 29,875 | +0.1% | 0.07% | -2.7% |
| Q3 2021 | $879,000 | -16.0% | 29,838 | -3.1% | 0.07% | -17.0% |
| Q2 2021 | $1,047,000 | +1.7% | 30,805 | -3.3% | 0.09% | -9.3% |
| Q1 2021 | $1,029,000 | -10.8% | 31,857 | -0.6% | 0.10% | -4.0% |
| Q4 2020 | $1,154,000 | -10.5% | 32,034 | -2.7% | 0.10% | -15.1% |
| Q3 2020 | $1,289,000 | -17.1% | 32,911 | -23.3% | 0.12% | -38.0% |
| Q2 2020 | $1,555,000 | -100.0% | 42,881 | -69.1% | 0.19% | -57.1% |
| Q1 2020 | $3,127,048,000 | +88939.0% | 138,566 | +15.0% | 0.45% | -12.2% |
| Q4 2019 | $3,512,000 | +28.8% | 120,466 | +17.8% | 0.51% | +18.9% |
| Q3 2019 | $2,727,000 | -8.5% | 102,251 | -13.0% | 0.43% | -10.4% |
| Q2 2019 | $2,979,000 | +16.5% | 117,587 | +3.0% | 0.48% | +14.6% |
| Q1 2019 | $2,558,000 | -8.6% | 114,169 | -14.0% | 0.42% | -16.4% |
| Q4 2018 | $2,798,000 | +4.2% | 132,803 | -8.4% | 0.50% | +16.3% |
| Q3 2018 | $2,684,000 | -15.1% | 144,963 | +2.3% | 0.43% | -19.0% |
| Q2 2018 | $3,161,000 | +4.5% | 141,690 | +3.0% | 0.53% | +1.5% |
| Q1 2018 | $3,024,000 | -4.4% | 137,595 | +1.1% | 0.52% | -7.6% |
| Q4 2017 | $3,163,000 | -18.8% | 136,115 | -19.8% | 0.57% | -23.1% |
| Q3 2017 | $3,895,000 | +7.3% | 169,638 | +3.2% | 0.74% | -1.7% |
| Q2 2017 | $3,630,000 | -85.9% | 164,388 | -85.4% | 0.75% | -87.4% |
| Q1 2017 | $25,682,000 | +11.4% | 1,125,895 | +2.2% | 5.93% | +28.3% |
| Q4 2016 | $23,047,000 | – | 1,101,654 | – | 4.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |